Abstract
About 5% of cancer patients treated with radiotherapy will have severe late-onset toxicity. Hyperbaric oxygen therapy (HBOT) has been used as a treatment for radiation injuries for decades, with many publications presenting data from small series or individual cases. Moreover, we know that the hypoxic areas of tumours are more resistant to radiation. HBOT increases the oxygen tension in tissues and, theoretically, it should enhance the efficiency of radiotherapy. To better understand how HBOT works, we carried out this bibliographic review. We found Grade B and C evidence that at pressures exceeding 2 absolute atmospheres (ata), HBOT reduced late-onset radiation injuries to the head and neck, bone, prostate and bladder. It also appeared to prevent osteoradionecrosis after exodontia in irradiated areas. Finally, HBOT at 2 ata increased the effectiveness of radiation in head and neck tumours and achieved promising results in the local control of high-grade gliomas.
Similar content being viewed by others
References
Fischer JJ, Rockwell S, Martin DF. Perfluorochemicals and hyperbaric oxygen in radiation therapy. Int J Radiat Oncol Biol Phys. 1986;122:95–102.
Marx RE, Johnson RP, Kline SN. Prevention of osteoradionecrosis: a randomized prospective clinical trial of hyperbaric oxygen versus penicillin. J Am Dent Assoc. 1985;111(1):49–54.
Svalestad J, Hellem S, Thorsen E, Johannessen AC. Effect of hyperbaric oxygen treatment on irradiated oral mucosa: microvessel density. Int J Oral Maxillofac Surg. 2015;44(3):301–7.
Lluis JM, et al. Especies reactivas y enfermedades. In: Konigsberg M, editor. Radicales libres y estrés oxidativo: aplicaciones médicas. México: Editorial El Manual Moderno; 2008. p. 331–476.
Speit G, Dennog G, Radermacher P, Rothfuss A. Genotoxicity of hyperbaric oxygen. Mutat Res Rev Mutat Res. 2002;512(2–3):111–9.
Corcoran T, et al. Hyperbaric oxygen therapy is not associated with oxidative stress assessed using plasma F2-isoprostanes and isofurans. Prostagland Leukot Essent Fatty Acids. 2017;127:16–9.
Rodbell M. Nobel lecture signal transduction: evolution of an idea. Environ Health Perspect. 1995;103(4):338–45.
Gomez-Quiroz LE, Cuevas-Bahena DB. ERO y señalización. In: Konigsberg M, editor. Radicales libres y estrés oxidativo: aplicaciones médicas. México: Editorial El Manual Moderno; 2008. p. 487–99.
Kendall AC, Whatmore JL, Harries LW, Winyard PG, Effleton P, Smerdon GR. Different oxygen treatment pressures alter inflammatory gene expression in human endothelial cells. Undersea Hyperb Med. 2013;40(2):115–23.
Spiegelberg L, Swagemakers SM, Van Ijcken WF, Oole E, Wolvius EB, Essers J. Gene expression analysis reveals inhibition of radiation-induced TGFβ-signaling by hyperbaric oxygen therapy in mouse salivary glands. Mol Med. 2014;20:257–69.
Evanger K, et al. Ocular refractive changes in patients receiving hyperbaric oxygen administered by oronasal mask or hood. Acta Ophtalmol Scand. 2004;82:449–53.
Hart GB, Strauss MB. Hyperbaric oxygen in the management of radiation injury. In: Proceedings 1st Swiss symposium on hyperbaric medicine. Basel: Stiftung für Hyperbare Medizin; 1986. Pp. 31–51.
Marx RE, Johnson RP, Kline SN. Prevention of osteoradionecrosis: a randomized prospective clinical trial of hyperbaric oxygen versus penicillin. J Am Dent Assoc. 1985;111:49–54.
Neovius EB, Lind MG, Lind FG. Hyperbaric oxygen therapy for wounds complications after surgery in the irradiated head and neck: a review of the literature and a report of 15 consecutive patients. Head Neck. 1997;19:315–22.
Alós M, Salvador M. Coste efectividad de la Terapia Hiperbárica en pacientes afectos de osteoradionecrosis de mandíbula y en los pacientes afectos de cistopatía hemorrágica y/o proctopatía hemorrágica radioinducidas. ISCIII: Informes de Evaluación de Tecnologías Sanitarias; 2009.
Low-Pressure fabric hyperbaric chambers. UHMS safety committee & UHMS oxygen therapy committee. 2017. https://uhmsblog.files.wordpress.com/2017/10/low-pressure-soft-chamber-uhms-position-statement-final.pdf. Accessed 21 Oct 2020.
Marshall GT, Thirlby RC, Bredfeldt JE, Hampson NB. Treatment of gastrointestinal radiation injury with hyperbaric oxygen. Undersea Hyperb Med. 2007;34(1):35–42.
European society for therapeutic radiology and oncology and European committee for hyperbaric medicine. Hyperbaric oxygen therapy in the treatment of Radio-induced lesions in normal tissues. 2001. http://www.echm.org/documents/ECHM. 5th Consensus Conference Lisbon 2001.pdf
Pavi J, Denekamp J, Letschert J. LENT-SOMA scales for all anatomic sites. Int J Radiat Oncol Biol Phys. 1995;31:1049–91.
Bennett MH, Feldmeier J, Hampson NB, Smee R, Milross C. Hyperbaric oxygen therapy for late radiation tissue injury. Cochrane Database Syst Rev. 2016;4:CD005005.
Mathieu D, Marroni A, Kot J. Recommendations for accepted and non-accepted clinical indications and practice of hyperbaric oxygen treatment. Div Hyperbar Med. 2017;47(1):24–32.
Güerci AM, Grillo CA. Evaluación del efecto genotóxico por exposición crónica a dosis bajas de radiación ionizante a través de un modelo in vitro. Radiobiología. 2007;7(2):166–73.
Horsman MR, Overgaard JS. The impact of hypoxia and its modification of the outcome of radiotherapy. J Radiat Res. 2016;57:90–8.
Shen G, Li X, Jia YF, Piazza GA, Xi Y. Hypoxia-regulated microRNAs in human cancer. Acta Pharmacol Sin. 2013;34(3):336–41.
Bruning U, Cerone L, Neufeld Z, Fitzpatrick SF, Cheong A, Scholz CC, et al. MicroRNA-155 promotes resolution of hypoxia-inducible factor 1 alpha activity during prolonged hypoxia. Mol Cell Biol. 2011;31(19):4087–96.
Zhu H, Chen XP, Luo SF, Guan J, Zhang WG, Zhang BX. Involvement of hypoxia-inducible factor-1-alpha in multidrug resistance induced by hypoxia in HepG2 cells. J Exp Clin Cancer. 2005;24(4):565–74.
Yang W, Sun T, Cao J, Liu F, Zhu W. Downregulation of miR-210 expression inhibits proliferation, induces apoptosis and enhances radio-sensitivity in hypoxic human hepatoma cells in vitro. Exp Cell Res. 2012;318(8):944–54.
Hahn R. Fortscnr Geb Rontgenstr Nuklearmed: ein beitrag zur rontgen therapie. Fortschr Geb Rontgenstr. Nukl. 1904;8:120–1.
Crabtree HG, Cramer W. The action of radium on cancer cells. R Soc Lond Proc Ser. 1933;B113:238–50.
Hall EJ. The oxygen effect and reoxigenation. In: Eric J, editor. Radiobiology for the radiologist. 3rd ed. Philadelphia: Lippincott, JB; 1994. p. 133–52.
Gray LH, Conger AD, Ebert M, Hornsey S, Scott OC. The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy. Br J Radiol. 1953;26:638–48.
Churchill-Davidson I, Sanger C, Thomlinson RH. Oxygenation in radiotherapy: clinical application. Br J Radiol. 1957;30:406–22.
Churchill-Davidson I. Hyperbaric oxygen and radiotherapy: clinical experiences. Nunt Radiol. 1968;34:215–25.
Kohshi K, Kinoshita Y, Terashima H, Konda N, Yokota A, Soejima T. Radiotherapy after hyperbaric oxygenation for malignant gliomas: a pilot study. J Cancer Res Clin Oncol. 1996;122:676–8.
Machin D, Stenning SP, Parmar MK, Fayers PM, Girling DJ, Stephens RJ, et al. Thirty years of Medical Research Council randomized trials in solid tumours. Clin Oncol. 1997;9:100–14.
Haffty BG, Hurley R, Peters LJ. Radiation therapy with hyperbaric oxygen at 4 atmospheres pressure in the management of squamous cell carcinoma of the head and neck: results of a randomized clinical trial. Cancer J Sci Am. 1999;5:341–7.
Hyperbaric oxygen therapy. COST B14. 2006. https://www.cost.eu/actions/B14/#tabs. Accessed 21 Oct 2020.
Kohshi K. New approaches for cancer treatments using hyperbaric oxygen therapy: radiotherapy, chemotherapy and control of brain radiation injury. In: 4th Karolinska Postgraduate Course in Clinical Hyperbaric Oxygen Therapy. Stockholm; 2006.
Kinoshita Y, Kohshi K, Kunugita N, Tosaki T, Yokota A. Preservation of tumour oxygen after hyperbaric oxygenation monitored by magnetic resonance imaging. Br J Cancer. 2000;82(1):88–92.
Overgaard J. Hypoxic radio-sensitization: adored and ignored. Clin Oncol. 2007;25(26):4066–74.
Ogawa K, Yoshii Y, Inoue O, Toita T, Saito A, Kakinohana Y, et al. Phase II trial of radiotherapy after hyperbaric oxygenation with chemotherapy for high-grade gliomas. Br J Cancer. 2006;95(7):862–8.
Ogawa K, Ishiuchi S, Inoue O, Yoshii Y, Watanabe T, Iraha S, et al. Phase II trial of radiotherapy after hyperbaric oxygenation with multiagent chemotherapy (procarbazine, minustine and vincristine) for high grade gliomas: long -term results. Int J Radiat Oncol Biol Phys. 2012;82(2):732–8.
Chen JR, Xu HZ, Ding JB, Qin ZY. Radiotherapy after hyperbaric oxygenation in malignant gliomas. Curr Med Res Opin. 2015;31(11):1977–84.
Huang L, Boling W, Zhang JH. Hyperbaric oxygen therapy as adjunctive strategy in treatment of glioblastoma multiforme. Med Gas Res. 2018;8(1):24–8.
Yahara K, Ohguri T, Udono H, Yamamoto J, Tomura K, Onoda T, et al. Radiotherapy using IMRT boosts after hyperbaric oxygen therapy with chemotherapy for glioblastoma. Radiat Res. 2017;58(3):351–6.
Kohshi K, Yamamoto H. Fractionated stereotactic radiotherapy using gamma unit after hyperbaric oxygenation on recurrent high-grade gliomas. J Neurooncol. 2007;82:297–303.
Hartford AC, FACR, Buckey JC, Roberts D, Li Z, Eskey C, et al. P10 Proof-of-principle study of hyperbaric oxygen (HBO) as a radio-sensitizer prior to stereotactic radiosurgery (SRS) for brain metastases (NCT01850563). Int J Rad Oncol Biol Phys suppl. 2018;101(2):24–5.
Clarke RH, Moosa S, Anzivino M, Wang Y, Floyd DH, Purow BW, et al. Sustained radio-sensitization of hypoxic glioma cells after oxygen pretreatment in an animal model of glioblastoma and in vitro models of tumor hypoxia. PLoS One. 2014;9(10):e111199.
Ding JB, Chen JR, Xu HZ, Qin ZY. Effect of hyperbaric oxygen on the growth of intracranial glioma in rats. Chin Med J (Eng). 2015;128(23):3197–203.
Bennett MH, Feldmeier J, Smee R, Milross C. Hyperbaric oxygenation for tumour sensitisation to radiotherapy. Cochrane Database Syst Rev. 2018;4:CD005007.
Sause WT, Plenk HP. Radiation therapy of head and neck tumors: a randomized study of treatment in air vs. treatment in hyperbaric oxygen. Int J Radiat Oncol Biol Phys. 1979;5(10):1833–6.
Funding
The Provincial Hospital of Castellón Foundation funded this work.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
All the authors declare that they have no conflicts of interest.
Ethical statements
This was an observational study. The Research Ethics Committee at the Castellón Provincial Hospital Consortium confirmed that no ethical approval was required for the completion of this work.
Informed consent
As a review article, no individual patient information or images were collected. Therefore, written informed consents were not required.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Fernández, E., Morillo, V., Salvador, M. et al. Hyperbaric oxygen and radiation therapy: a review. Clin Transl Oncol 23, 1047–1053 (2021). https://doi.org/10.1007/s12094-020-02513-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12094-020-02513-5